CTLA4 and systemic sclerosis: Of note, the ability of CTLA4-Ig to trigger a decrease in the expression of CXCR4 and CD11a adhesion/migration molecules on SSc circulating fibrocytes may suggest its possible action in interfering with trafficking and migration of these cells into inflammatory/altered sites [10, 14].